title: Irisin levels are associated with urotensin II levels in diabetic patients.
abstract: OBJECTIVE
  Irisin is a newly identified myokine that can promote energy expenditure. Previous studies showed that circulating urotensin II (UII) levels were increased in diabetes, and UII could inhibit the glucose transport in skeletal muscle in diabetic mice and aggravated insulin resistance. We presumed that irisin levels are associated with UII in diabetic patients.
  
  
  METHODS
  A total of 71 patients with type 2 diabetes and 40 healthy subjects were recruited. Blood and urinary irisin concentrations were measured by using enzyme-linked immunosorbent assay, and UII concentrations were measured by bioelectrical impedance analysis. Every participant's body composition was analyzed by bioelectrical impedance.
  
  
  RESULTS
  The serum irisin levels were significantly lower in diabetic patients than that of controls, whereas serum UII levels were significantly higher in diabetic patients than that in that of controls. Serum irisin levels were negatively associated with circulating UII, hemoglobin A1c and the natural logarithm transformation of urinary albumin excretion, whereas serum irisin was positively associated with estimated glomerular filtration rate, and low-density lipoprotein cholesterol and urinary irisin were positively associated with urinary UII. Furthermore, circulating irisin is positively associated with muscle mass, whereas circulating UII is negatively associated with muscle mass in diabetic patients. Hemoglobin A1c and circulating UII are independent determinants of circulating irisin by multiple regression analysis.
  
  
  CONCLUSIONS
  The present results provide the clinical evidence of an association between irisin and UII in diabetic patients. Hemoglobin A1c and circulating UII are independent determinants of circulating irisin. Our results hint that UII and high glucose might inhibit the release of irisin from skeletal muscle in diabetic patients.
authors.affiliation: Department of Nephrology, Peking University Third Hospital Beijing, China.
authors.forename: Wan-Yu
authors.initials: WY
authors.lastname: He
authors.affiliation: Department of Nephrology, Peking University Third Hospital Beijing, China.
authors.forename: Qiong
authors.initials: Q
authors.lastname: Bai
authors.affiliation: Department of Nephrology, Peking University Third Hospital Beijing, China.
authors.forename: La-Ta
authors.initials: LT
authors.lastname: A
authors.affiliation: Department of Pathology and Physiology, Peking University Health Science Center Beijing, China.
authors.forename: Chao-Shu
authors.initials: CS
authors.lastname: Tang
authors.affiliation: Department of Nephrology, Peking University Third Hospital Beijing, China.
authors.forename: Ai-Hua
authors.initials: AH
authors.lastname: Zhang
keywords: Irisin; Type 2 diabetes; Urotensin II